Navigation Links
Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care

es information from 28 tender and swollen joints (range 0-28), erythrocyte sedimentation rate, and a general health assessment on a visual analog scale. The level of disease activity is interpreted as low (DAS28 less than or equal to 3.2), moderate (3.2 < DAS28 less than or equal to 5.1) or high (DAS28 >5.1). DAS28 <2.6 corresponds to being in remission according to the criteria of the American Rheumatism Association (ARA). (3) The EULAR response criteria is based on the individual amount of change in DAS and the DAS value (low, moderate, high disease activity) reached to classify patients as good, moderate and non-responders.

CONTACT: Ginny Valenze of Roche, Office, +1-973-562-2783, Cell,+1-973-943-9219, ; or Becky Lauer of ManningSelvage & Lee, Office, +1-212-468-4125, Cell, +1-917-592-9260, virginia.valenze@roche.com becky.lauer@mslpr.com

Web site: http://www.rocheusa.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
2. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
3. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
6. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
7. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
8. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
9. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
10. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
11. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
Post Your Comments:
(Date:1/6/2009)... In recent controlled studies condu...s , scientists found that the patented ingredient ...nly proven ingredient to increase levels of nitric...nitrate/nitrate (NOx) in human subjects. , , Ni...crease in blood flow to the skeletal muscles. Thi...
(Date:1/6/2009)...uary 6 , - Early ...on Until,December 2011 , - Expansion of th...Discovery in Ophthalmology , - Revised Comm...Sublicenses to a Third Party , ExonHit Th...inforcement,of its existing drug discovery collab...
(Date:12/30/2008)...RNewswire-USNewswire/ -- The Coalition for 21st Ce...on filed by Genentech, Inc. on December 5, 2008, s...offer diagnostic tests to physicians and patients....ests, would harm patient care and rests on flawed ...n,s mission is to encourage the research, developm...
(Date:12/17/2008)...in development and validation of non-animal altern... 17 MatTek Corporation today annou...(ESAC) endorsed the scientific validity of the Mod...vember meeting. ESAC concluded that the Modified ...y for the prediction of skin irritating and non-ir...
Breaking Medicine Technology:US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4EpiDerm's Skin Irritation Test Fully Validated in European Union 2Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis 28PGD 29 1249 1Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis 28PGD 29 1249 2Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis 28PGD 29 1249 3Pharsight Expands Global Consulting Services Teams 3640 1Pharsight Expands Global Consulting Services Teams 3640 2Pharsight Expands Global Consulting Services Teams 3640 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 1Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 2Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 4Study 3A Modafinil is effective in treating excessive sleepiness 3637 1Study 3A Modafinil is effective in treating excessive sleepiness 3637 2
...swire-FirstCall/ -- Vical,Incorporated today annou...e company,s Vaxfectin(TM) adjuvant elicited protec... (1 - 2 year old),nonhuman primates confirmed by c...ne year after vaccination, and sterilizing,immunit... no,detectable virus after challenge. In a separat...
...007 /PRNewswire-FirstCall/ -- Alexza,Pharmaceutica...he,49th Annual American Headache Society Meeting t...to(R) prochlorperazine (AZ-001),for the acute trea...n, "Efficacy and tolerability profile of AZ-001,(S...e headache",(Poster S-72), will be available for v...
Other Medicine Technology:Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2
(Date:1/8/2009)...swire/ -- A study released this week showing that ...ultiple chronic diseases shines a much-needed spot...stem to one that focuses on primary and secondary ... the leader in disease prevention. , , (Logo:...TU129LOGO ) , , The study, conducted by Socia...
(Date:1/8/2009)...ember Tom Torlakson Introduces AB 89 , , SACRAM...Today, Lung Cancer Alliance-California (LCA-CA), h...11th District) for his continued leadership in int...ncer research. For the third consecutive year, le...being considered in the California Legislature. ...
(Date:1/8/2009)...emn hurtful comments, study suggests , ,... overestimate how strongly they would react to rac...hree percent of study participants at York Univers...eriment with a white person rather than a black on...s about the black person when he left the room. ,...
(Date:1/8/2009)...8 Hanger Orthopedic Grou... throughout the fourth quarter of 2008 it acquired...y Mountain Orthotic-Prosthetics Center, Riessen,s ...ast Orthotics & Prosthetics, and Orthopedic Re... patient care centers to existing markets in Maine...
Breaking Medicine News(10 mins):Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Many Turn Blind Eye to Racism 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2
...ique Federale de Lausanne) and the CHUV (Lausanne ...ls in the hair follicle belong to the true multipo...nto many cell types needed for hair growth and fol...has documented its findings in an advance online p...
...ue of the journal Pediatrics says that the cavity ... of Cow's milk. Dr. Ruth A. Lawrence of the Unive...e Dr. William H. Bowen used rats to demonstrate th...se tooth decay faster than cow's milk. Baby mice d...
...of Multiple Sclerosis (MS), has been withdrawn fro...mplained of neurological disorders. The relationsh...Leukoencephalopathy (PML) is being researched by t...gnificant risk, it could be a serious setback for ...
...g a glassful of dangerous bacteria, not many will ...however did just that. He swallowed a cocktail of ...rial in origin rather than stress or lifestyle-rel... proved very useful as his colleague Robin Warren ...
Other Medicine News:Health News:Nobel For Ulcer-Defying Aussie Scientists 2
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm).
Key periosteal elevators, blade width 1" (25 mm), total length 7 1/2" (191 mm).
Hoen periosteal elevators, No.3, blade width 3/4" (20 mm), total length 7 1/2" (191 mm).
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm).
Medicine Products: